Nargenicin
Nargenicin is a macrolide antibiotic that is produced by the bacterium Nocardia argentinensis. It is known for its potent antibacterial activity against a wide range of Gram-positive bacteria, including drug-resistant strains such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).
History[edit | edit source]
Nargenicin was first isolated from Nocardia argentinensis in the 1970s. Since then, it has been the subject of numerous studies due to its potent antibacterial activity and unique mechanism of action.
Structure and Mechanism of Action[edit | edit source]
Nargenicin is a 16-membered macrolide antibiotic. Its structure is characterized by a large macrocyclic lactone ring, to which various sugar moieties are attached. This complex structure is believed to be responsible for its potent antibacterial activity.
The exact mechanism of action of nargenicin is not fully understood. However, it is believed to inhibit protein synthesis in bacteria by binding to the 50S ribosomal subunit, thereby preventing the translocation of peptidyl-tRNA from the A-site to the P-site of the ribosome.
Clinical Use[edit | edit source]
Despite its potent antibacterial activity, nargenicin is not currently used in clinical practice. This is primarily due to its poor solubility and stability, which make it difficult to formulate into a suitable dosage form. However, research is ongoing to develop new formulations of nargenicin that overcome these limitations.
Research and Development[edit | edit source]
In recent years, there has been renewed interest in nargenicin due to the increasing prevalence of drug-resistant bacteria. Several studies have shown that nargenicin is active against a wide range of drug-resistant bacteria, including MRSA and VRE. This has led to the suggestion that nargenicin could be used as a last-resort treatment for infections caused by these bacteria.
In addition to its antibacterial activity, nargenicin has also been shown to have anticancer activity. This has led to the suggestion that it could be used as a novel anticancer agent.
See Also[edit | edit source]
- Need help finding a doctor or specialist anywhere in the world? WikiMD's DocFinder can help with millions of doctors!
| This article is a stub. Help WikiMD grow by registering to expand it. |
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD
